Go to Total Probiotics Supplement (click here)

Product # 2405 (60 cap size)

#2405-A (120 cap size)

Researched by and Formulated for Dr. John  Brimhall, D.C.)


Each capsule supplies:  Jerusalem Artichoke (rich source of fructooligosaccharides) 200mg, Cellulase 1200 CU, Lactobacillus Acidophilus 400 million, Acerola Extract 25mg, Rose Hips 25mg, Bifidobacterium Bifidum 200 million, Bifidobacterium Longum 200 million, Protease 7500 HUT, Lipase 52 LU, Lactobacillus Casei 100 million, Lactobacillus Plantarum 100 million, Lactobacillus Rueteri 100 million, Lactobacillus Salivarius 100 million, Amylase 275 DU, EDS Mineral Mix (Kelp, calcium Ascorbate, Magnesium Citrate Zinc Gluconate, Manganese Gluconate in a base of pure plant fiber.  We suggest you refrigerate after opening.


Recommendation: 1 capsules 3 x day or as directed





Current dietary habits, wrong food combinations, excessive use of sweets and other refined carbohydrates and indiscriminate use of antibiotics have yielded many complications to our health.  The sad note is, that 50% of all antibiotics sold are used in the raising of animals for slaughter.  They say this gives the animals a  faster weight gain with fewer infections.  What it gives us, is death of our normal  intestinal bacteria .  This yields symptoms of gas, indigestion, bloating,  and yeast overgrowth.


 Billions of beneficial micro-organisms are suppose to live in our intestinal track which keep the intestines clean by feeding  on the putrefaction, waste, fungus, yeast and other harmful bacteria.  These beneficial microorganisms also aid the body in producing the essential elements such as hormones, vitamins, and proteins that are needed to run our body .


Research is showing that each of these cultures attaches at different sights in the intestines and can live synergistically together.  Below is a list of the seven different bacteria along with their functions.


1.      LACTOBACILLUS ACIDOPHILUS is known to thwart the growth of pathogenic microorganisms, including Candida albicans, by producing both lactic acid and antibiotic compounds.  This probiotic also helps minimize the symptoms of dairy intolerance.


2 & 3.  BIFIDOBACTERIA (B, BIFIDUS also inhibit the growth of pathogenic organisms. Research shows that nitrite-producing organisms are specifically inhibited by these probiotics.


4. LACTOBACILLUS PLANTARUM produces a high percentage of lactic acid, which acts to inhibit harmful microorganisms.


5.  LACTOBACILLUS SALIVARIUS has been shown to produce alpha-galactosidase which can help reduce flatulence.  In addition, L-Salivarius has been shown to be highly resistant to tetracycline and chloramphenicol antibiotics.


6.  LACTOBACILLUS RUELERI has been shown to stabilize the intestinal flora and is used with L. acidophilus and bifidobacteria as extra support.  L.rueleri promotes additional benefits such as protection against pathogens, provision of certain nutrients and enzymatic reactions, involvement in tissue morphogenesis, peristalsis activity and interaction with the immune and endocrine systems.


7.  LACTOBACILLUS CASEI creates a desirable microbial balance and controls the production of toxins upon vital organs and body cells.  L.casei contributes to intestinal peristalsis and elimination of harmful amines from amino acids.  L.casei coats the intestinal mucosa and protects against invasion and activities of harmful organisms.  L-casei provides constant protection in the digestive tract to promote better nutrition and health.





Brochu, E. "Special Behavior of Lactic Bacteria and their Relation to Nutrition and Health", (Roselle Institute, Inc., Lecture August 10, 1986.


Collins, B., Hardt, P. "Inhibition of Candida Albicans by Lactobacillus Acidophilus". J.DAIRY SCI. 63: 830-2 (1980).


Conway, P.L., Gorbach, S.L., Goldin, B.R., "Survival of Lactic Acid Bacteria in the Human Stomach and Adhesion to Intestinal Cells". J.DAIRY SCI. 70; 1-12 (1987).


Chose, T.K. and  Pathak, A.M. "Cellulase-2 Applications", Process Biochemistry, 20-24, May 1973.


Gilliland, S.E. "Beneficial interrelationships between certain microorganisms and humans:  Candidate microorganisms for use as dietary adjuncts". J. Food Production 42; 146-67 (1979)


Homma, N. "Bifidobacteria as a resistance factor in human beings".  BIFIDOBACT, MICROFLORA 7 (1) 35-43 (1988)


Mitsuoka, T. "Recent Trends in Research on Intestinal Flora: Taxonomy and Ecology of Bifidobacteria". BIFIDOBACT, MICROFLORA  1:3-24 (1982)


Schwimmer, S. Source Book of Food Enzymology. (Westport, C.T:  The AVI Publishing Company, Inc., 1981)


Speck, M.L. "Interactions Among Lactobacilli and Man", J. DAIRY SCI. 59; 338-43.



The above statements have not been evaluated by the FDA.  The nutritional information, suggestions, and research provided are not intended to diagnose, treat, cure, or prevent disease and should not be used as a substitute for sound medical advice.  Please see your health care professional in all matters pertaining to your physical health.

Close Window   Print Document  home, total supplements Home